MicuRx Announces Funding from CARB-X for Innovative Polymyxin Antibiotic MRX-8

HAYWARD, Calif. and SHANGHAI, China, March 5, 2018 /PRNewswire/ — MicuRx Pharmaceuticals, Inc. today announced that the global partnership Combating Antibiotic Resistant Bacteria Accelerator (CARB-X) has committed up to $5.2 million of non-dilutive financing for IND enablement and…